Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion type Assertion NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_head.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion evidence source_evidence_literature NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion SIO_000772 23210512 NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion wasDerivedFrom befree-20140225 NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.
- NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion wasGeneratedBy ECO_0000203 NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.